SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Ghidini, A.M. Capelli, C. Carnini, V. Cenacchi, G. Marchini, A. Virdis, A. Italia, F. Facchinetti, Discovery of a novel isoxazoline derivative of prednisolone endowed with a robust anti-inflammatory profile and suitable for topical pulmonary administration, Steroids, 2015, 95, 88

    CrossRef

  2. 2
    Christopher D. Pascoe, Nicholas E. Swyngedouw, Chun Y. Seow, Peter D. Paré, Gene expression in asthmatic airway smooth muscle: a mixed bag1, Canadian Journal of Physiology and Pharmacology, 2015, 93, 2, 137

    CrossRef

  3. 3
    Christine R. Keenan, Danica Radojicic, Meina Li, Asmaa Radwan, Alastair G. Stewart, Heterogeneity in mechanisms influencing glucocorticoid sensitivity: The need for a systems biology approach to treatment of glucocorticoid-resistant inflammation, Pharmacology & Therapeutics, 2015,

    CrossRef

  4. 4
    T Joshi, M Johnson, R Newton, M A Giembycz, The long-acting β2-adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner, British Journal of Pharmacology, 2015, 172, 8
  5. 5
    Robert Newton, Anti-inflammatory glucocorticoids: Changing concepts, European Journal of Pharmacology, 2014, 724, 231

    CrossRef

  6. 6
    L. Bechmann, K. Busse, M. Stoppe, S. Cotte, B. Ettrich, F. Then Bergh, Corticosteroid receptor expression and in vivo glucocorticoid sensitivity in multiple sclerosis, Journal of Neuroimmunology, 2014, 276, 1-2, 159

    CrossRef

  7. 7
    Mark A Giembycz, Donald H Maurice, Cyclic nucleotide-based therapeutics for chronic obstructive pulmonary disease, Current Opinion in Pharmacology, 2014, 16, 89

    CrossRef

  8. You have free access to this content8
    A. S. Zannas, E. B. Binder, Gene–environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism, Genes, Brain and Behavior, 2014, 13, 1
  9. 9
    Mark A. Giembycz, Robert Newton, How Phosphodiesterase 4 Inhibitors Work in Patients with Chronic Obstructive Pulmonary Disease of the Severe, Bronchitic, Frequent Exacerbator Phenotype, Clinics in Chest Medicine, 2014, 35, 1, 203

    CrossRef

  10. 10
    Riku Korhonen, Eeva Moilanen, Mitogen-Activated Protein Kinase Phosphatase 1 as an Inflammatory Factor and Drug Target, Basic & Clinical Pharmacology & Toxicology, 2014, 114, 1
  11. 11
    Mariona Pinart, Farhana Hussain, Sima Shirali, Feng Li, Jie Zhu, Andrew R. Clark, Alaina J. Ammit, Kian Fan Chung, Role of mitogen-activated protein kinase phosphatase-1 in corticosteroid insensitivity of chronic oxidant lung injury, European Journal of Pharmacology, 2014, 744, 108

    CrossRef

  12. 12
    Richard Mott, Wei Yuan, Pamela Kaisaki, Xiangchao Gan, James Cleak, Andrew Edwards, Amelie Baud, Jonathan Flint, The Architecture of Parent-of-Origin Effects in Mice, Cell, 2014, 156, 1-2, 332

    CrossRef

  13. 13
    Peter J. Barnes, Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease, Journal of Allergy and Clinical Immunology, 2013, 131, 3, 636

    CrossRef

  14. 14
    Ching Yong Yick, Aeilko H. Zwinderman, Peter W. Kunst, Katrien Grünberg, Thais Mauad, Kees Fluiter, Elisabeth H. Bel, René Lutter, Frank Baas, Peter J. Sterk, Glucocorticoid-induced Changes in Gene Expression of Airway Smooth Muscle in Patients with Asthma, American Journal of Respiratory and Critical Care Medicine, 2013, 187, 10, 1076

    CrossRef

  15. 15
    Anthony N. Gerber, Glucocorticoids and Airway Smooth Muscle: Some Answers, More Questions, American Journal of Respiratory and Critical Care Medicine, 2013, 187, 10, 1040

    CrossRef

  16. 16
    Lyn M. Wancket, W. Joshua Frazier, Yusen Liu, Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease, Life Sciences, 2012, 90, 7-8, 237

    CrossRef